版本:
中国

BRIEF-Verona Pharma announces pricing of global offering, approval to list on NASDAQ

April 26 Verona Pharma Plc

* Verona Pharma announces pricing of global offering and approval to list on the NASDAQ global market

* Pricing of its global offering comprising 5.7 million American Depositary Shares at a price of $13.50 per ADS

* Pricing of global offering also comprising 1.2 million ordinary shares at a price of £1.32 per ordinary share Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐